Carol L. Brosgart, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carol L. Brosgart, M.D.
Earlier roles on record: Board Member at Mirum Pharmaceuticals, Inc. (MIRM) until December 19, 2022. Mirum Pharmaceuticals, Inc. reported in an 8-K filed December 19, 2022 that Carol L. Brosgart, M.D. resigned as director, effective December 19, 2022.
“On December 16, 2022, Carol L. Brosgart, M.D., notified the board of directors (the "Board") of Mirum Pharmaceuticals, Inc. (the "Company") of her resignation as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective December 19, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-06-04–2022-12-19
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.